Improving emotion regulation through personalized treatment approaches
A Precision Medicine Approach to Target Engagement for Emotion Regulation
This study is looking at how to improve emotional support for people with mental health challenges by figuring out which parts of current treatments work best for different individuals, so that therapy can be more personalized and effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11013390 on NIH RePORTER |
What this research studies
This research focuses on understanding how to better help individuals manage their emotions, particularly those struggling with psychiatric disorders. It aims to identify which specific components of existing treatments are most effective for different patients, allowing for a more tailored approach to therapy. By using advanced experimental designs, the research will explore how these treatments can be adapted to meet individual needs, potentially leading to more effective outcomes. The ultimate goal is to develop scalable interventions that can be widely implemented in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing difficulties with emotion regulation, particularly those with psychiatric disorders such as anxiety or borderline personality disorder.
Not a fit: Patients who do not struggle with emotion regulation or who have stable emotional health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for individuals with emotional dysregulation, improving their overall mental health and quality of life.
How similar studies have performed: Previous research has shown promise in tailoring psychological interventions to individual needs, suggesting that this approach could yield significant benefits.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Southward, Matthew Wayne — University of Kentucky
- Study coordinator: Southward, Matthew Wayne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.